Reference
US Food and Drug Administration. Zyprexa Relprevv (olanzapine pamoate): Drug Safety Communication - FDA Review of Study Sheds Light on Two Deaths Associated with the Injectable Schizophrenia Drug. Internet Document : 23 Mar 2015. Available from: URL: http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm439472.htm
Rights and permissions
About this article
Cite this article
US FDA reviews deaths following Zyprexa Relprevv therapy. Reactions Weekly 1545, 8 (2015). https://doi.org/10.1007/s40278-015-9099-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-015-9099-x